IDP-Inspired Nanovector Coacervates for Efficient Cytosolic mRNA Delivery

Study Background and Research Question

In eukaryotic cells, membraneless organelles (MLOs) utilize liquid–liquid phase separation (LLPS) to compartmentalize and traffic biomacromolecules without reliance on vesicular transport. This process, governed by the dynamic interactions of intrinsically disordered proteins (IDPs), allows rapid, energy-efficient exchange between organelles and the cytoplasm. Synthetic coacervates, inspired by these natural structures, have emerged as promising platforms for cargo delivery in molecular biology and biomedical research. However, the lack of conformational adaptability in many synthetic systems limits their stability, internalization mechanisms, and ultimately, their translational potential. The referenced study (Jin et al., 2025) addresses this challenge by engineering nanovectors modeled after the flexible, adaptive properties of IDPs, aiming to improve the cytosolic delivery of diverse biomacromolecules including mRNA, proteins, and genome-editing units.

Key Innovation from the Reference Study

The primary innovation lies in the development of IDP-inspired nanovectors (IDP-NVs) capable of forming nanocoacervates (NCs) with various biomacromolecular cargos. Drawing on the distinctive sticker–spacer architecture of natural IDPs, the nanovectors display conformational plasticity, enabling optimized interaction with a spectrum of biomolecules. The resulting NCs demonstrate stability under physiological conditions and are able to bypass endosomal entrapment, directly penetrating cell membranes through active molecular motion. The release of cargo is precisely triggered by cytosolic glutathione, which induces NC disassembly and enables immediate cytosolic access for the delivered biomacromolecules (Jin et al., 2025).

Methods and Experimental Design Insights

The researchers synthesized IDP-NVs by mimicking the modular composition of natural IDPs: a flexible interaction module (sticker) confers binding adaptability, while a spacer domain modulates the distance and strength of intermolecular interactions. The formation of NCs was achieved by simple mixing of nanovectors with target biomacromolecules under physiological buffer conditions. Advanced microscopy and spectroscopy techniques confirmed the dynamic, phase-separated nature of the NCs and their stability in the presence of physiological salt and serum.

To assess delivery efficacy, a range of cargos—including globular proteins, antibodies, mRNA constructs, and CRISPR/Cas9 components—were encapsulated and delivered to mammalian cell lines. The internalization mechanism was probed using pharmacological inhibitors and live-cell imaging, confirming direct membrane penetration rather than endocytic uptake. Disassembly and cytosolic release were tracked by exploiting the cell's endogenous glutathione as a redox trigger, ensuring that the cargo was released only after successful cytosolic entry.

Core Findings and Why They Matter

The study's findings affirm that IDP-NV-based NCs provide several critical advantages for biomacromolecule delivery:

• Physiological Stability: Unlike many traditional coacervates, these NCs remain stable in complex biological fluids, resisting aggregation and premature disassembly (Jin et al., 2025).
• Direct Cytosolic Entry: NCs bypass the endosomal pathway, minimizing degradation and maximizing functional delivery.
• Triggerable Release: The use of cytosolic glutathione as a disassembly signal ensures precise, intracellular cargo release.
• Versatility: The system successfully delivered a wide range of biomacromolecules, including mRNAs, globular proteins, and CRISPR units, highlighting its broad utility for molecular biology, gene editing, and therapeutic development.

These advances are especially relevant for researchers working on mRNA delivery and translation efficiency assay development, as they address key bottlenecks such as cytosolic access and cargo stability. The results suggest that biomimetic, IDP-inspired nanovectors could significantly enhance the performance and reliability of bioluminescent reporters and other functional nucleic acids within living systems.

Comparison with Existing Internal Articles

Recent internal literature has highlighted the importance of mRNA structure and delivery strategy in optimizing reporter assay sensitivity and reproducibility. For example, EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure has been shown to improve in vivo stability and translation efficiency due to its enhanced 5' capping and poly(A) tail design. These improvements align with the goals of the present study, which seeks to maximize functional delivery and expression in cellular contexts.

Notably, internal reports emphasize that the Cap 1 structure reduces innate immune activation while supporting robust, quantifiable bioluminescent output—features that complement the IDP-NV platform by ensuring that once the mRNA is delivered to the cytosol, it is both stable and highly translatable. Therefore, combining advanced delivery systems such as IDP-inspired NCs with engineered reporter mRNAs may provide a synergistic approach for in vivo bioluminescence imaging, gene regulation reporter assay development, and molecular probe optimization.

Limitations and Transferability

While the IDP-NV platform marks a substantial step forward, several considerations remain:

• In Vivo Translation: Most experiments were conducted in vitro or in cell culture. The biocompatibility, biodistribution, and long-term effects of these nanovectors in whole organisms require further study.
• Cargo Size Limits: Although diverse biomacromolecules were tested, there may still be practical size or charge constraints for certain therapeutic or diagnostic applications.
• Redox Sensitivity: The dependency on intracellular glutathione for release is elegant, but variations in redox state across cell types or disease conditions could influence delivery predictability.

Despite these limitations, the core principle—leveraging biomimetic, phase-separating nanovectors for direct cytosolic delivery—shows strong promise for translation to a range of molecular biology and biomedical workflows.

Protocol Parameters

• NC Formation: Combine IDP-inspired nanovectors with desired cargo (e.g., capped mRNA, proteins) in physiological buffer at room temperature; adjust nanovector-to-cargo ratio empirically for optimal encapsulation.
• Delivery to Cells: Add freshly prepared NCs directly to cell culture media; incubation times from 2–8 hours are typical for efficient uptake in adherent mammalian cells.
• Redox-Triggered Release: Ensure sufficient cellular glutathione levels for efficient NC disassembly; consider pre-treating cells with glutathione precursors if required by experimental design.
• Reporter Assay Readout: For mRNA delivery and translation efficiency assay, use firefly luciferase mRNA with Cap 1 structure for sensitive, quantifiable bioluminescent output post-delivery.

Research Support Resources

To implement similar mRNA delivery and translation efficiency assays, researchers may consider using EZ Cap™ Firefly Luciferase mRNA (SKU R1018), which features a Cap 1 structure and optimized poly(A) tail to enhance stability and translation in cellular contexts. This reagent is suitable for applications in gene regulation reporter assays, in vivo bioluminescence imaging, and workflow benchmarking alongside delivery platforms such as IDP-inspired nanocoacervates. For further protocol integration and evidence-based guidance, recent internal articles discuss the molecular advantages and application strategies for next-generation capped mRNAs in translational research.